South Korea MFDS registration In Vitro Water No. 23-345
HIV· HBV· HCV· HTLV serotype and subtype test reagent
KO: HIV·HBV·HCV·HTLV혈청형·아형검사시약
Basic information
- Item Serial Number
- 2023006107
- License Number
- In Vitro Water No. 23-345
- Classification Number
- K05020.01
- Device Class (Risk Classification)
- Unknown
- Classification Name
- HIV· HBV· HCV· HTLV serotype and subtype test reagent
- Official English Name
- IVD reagents for serotyping or patient monitoring of HIV, HBV, HCV, HTLV, immunological method
체외수허23-345호
HIV·HBV·HCV·HTLV혈청형·아형검사시약
Company information
- Category
- In vitro diagnostic import business
- Business License Number
- 체외 제 390 호
체외진단수입업
Important dates & status
- Item Approval Date
- Oct 26, 2023
- Business Permit Date
- Apr 04, 2005
- Expiration Period
- 2023-10-26 ~ 2028-10-25
Model information
- Model Name
- ADVIA Centaur Anti-HBe2 (aHBe2)
About this record
This Unknown medical device is registered with South Korea's Ministry of Food and Drug Safety (MFDS / 식품의약품안전처) under license number In Vitro Water No. 23-345. Approved on Oct 26, 2023. Registered by Siemens Healthineers Co., Ltd..
Pure Global AI provides free access to comprehensive South Korea MFDS registration data, helping global MedTech companies analyze market presence and regulatory compliance for medical devices in South Korea.
Free DatabasePowered by Pure Global AIMFDS Official DataUnknown